Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Telix Opens TMS Yokohama in Japan, Commemorative Lecture Held 2025-11-21 14:22
NovaBridge's Visara Subsidiary Appoints Distinguished Ophthalmology Leaders as Chief Medical Officer and Scientific Advisory Board Chair to Drive VIS-101 Forward 2025-11-21 13:46
Everest Medicines Announces First Patient Dosed in a Global Multi-Center Phase I Clinical Trial of Tumor-Associated Antigen Cancer Vaccine EVM14 2025-11-21 12:01
HitGen Receives New Funding to Discover Novel Therapeutics for Underserved Diseases 2025-11-20 22:30
Henlius' Serplulimab (anti-PD-1 mAb) Granted Breakthrough Therapy Designation by China NMPA for Neo-/Adjuvant Treatment for Gastric Cancer 2025-11-20 18:52
WuXi AppTec Receives Frost & Sullivan's 2025 Global Company of the Year Recognition in the CRDMO Industry 2025-11-20 10:00
ZIRCON-X Analysis: TLX250-CDx Impacts Clinical Decision Making for Almost Half of Patients with Indeterminate Renal Masses 2025-11-20 03:00
Accelerating Drug Discovery: Tsingke Biotech Unveils Next-Generation Rapid Protein and Antibody Solutions 2025-11-19 22:17
Nona Biosciences and Pfizer Announce Strategic Research Collaboration to Accelerate Antibody Discovery 2025-11-19 20:08
Lynk Pharmaceuticals Announces Key Phase II Clinical Results of LNK01004 for the Treatment of Patients with Moderate-to-Severe Atopic Dermatitis 2025-11-19 08:00
Kangpu to Present Latest Study Results of epaldeudomide (KPG-818) at the 67th ASH Annual Meeting 2025-11-18 21:00
Ajinomoto Bio-Pharma Services Wins "Best ADC Preclinical Publication 2024" Award for AJICAP® Technology at 2025 World ADC Awards 2025-11-17 22:26
Henlius and Organon Announce US FDA Approval of POHERDY® (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US 2025-11-17 22:06
Akeso's Bispecific Antibody Targeting Aβ and BBB-Expressed Receptor Approved for Alzheimer's Disease Clinical Trials in China 2025-11-17 10:29
Lundbeck files for marketing authorization across key Asian markets for Vyepti® (eptinezumab) for the preventive treatment of migraine 2025-11-14 17:43
PRISM BioLab Achieved Initial Milestone and Receives the Milestone Payment in Drug Discovery Collaboration with Ono Pharmaceutical Co., Ltd. 2025-11-14 16:00
Fosun International Receives "ESG & Corporate Sustainability Excellence Award" from Hong Kong Economic Journal 2025-11-14 09:00
Herbalgy Unveils a New Campaign Featuring Cecilia Yeung in Conversation with Professor Wong Tin Chee Introducing Touch-Cool 5 ml Portable Edition and the New Herbalgy Analgesic Plaster 2025-11-14 09:00
LISCure Expands Global Partnerships for BBB Shuttle Platform 'ExoPN-101'; Signs Fourth MTA with Leading Pharma Partner 2025-11-13 21:00
HKSH Medical Group Hosts Hong Kong's First Asia-Oceania Particle Therapy Co-operative Group Conference 2025-11-13 19:22
1 4 5 6 7 8 481